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Introduction
Cyclic peptides are increasingly important and serve as relevant lead structures and bioactive molecules in medicinal chemistry and drug design since they offer a plethora of biological activities and are especially interesting for the modulation of protein-protein interactions.
1 Their (total) synthesis, however, is still a highly challenging task and the development of novel and efficient cyclization approaches is an active field of research. 1f Within this class, multicyclic as well as side-chain knotted cyclic peptides, including the conotoxins and cyclotides, 2 lantibiotics, 3 and glycopeptide antibiotics, 4 are of special interest since they combine extreme potency with shape persistent folding of the peptide backbone. The most classical and outstanding example of the effects of macrocyclization and side-chain knotting is found in the heptapeptide vancomycin. 5 These lead to an almost absolute control of shape and folding of this glycopeptide antibiotic and allows for a very strong binding of the rather flexible natural target $Lys-DAla-D-Ala-OH.
6
Over the years we have been inspired by cyclized peptides such as vancomycin as well as nisin and have explored alternative approaches for peptide cyclization, among others, Sonogashira cross-coupling, 7 ring closing metathesis, 8 and Cu + as well as Ru
2+
catalyzed azide-alkyne cycloadditions, 9 to obtain highly constrained side-chain to side-chain knotted peptides. Previously, we have shown that alkyne-, alkene-and triazole-tethered cyclic tri-, hexa-and heptapeptides could be synthesized that mimic vancomycin by binding $Lys-D-Ala-D-Ala-OH and $Lys-D-Ala-D-Lac-OH. To further increase the rigidity of these mimics, we were looking for complementary cyclization approaches for introducing an additional cyclic constraint to control the sequence of cyclization and thereby the folding topology of the peptide backbone. So far, most vancomycin mimics, including our own, have focused mainly on the CDE-ring system. 10 However, the ABC-ring system probably provides the additional needed rigidity in the form of a lid, making vancomycin more of a clam to hold $Lys-D-Ala-D-Ala-OH more permanently by reducing the off-rate. Herein, we describe our efforts toward effective mimicry of the ABC-ring system, 10 h,11,12 which ultimately combined with DE-mimicry should lead to potent vancomycin mimics.
Results and discussion
Previously, we have reported the synthesis of triazole-containing vancomycin mimics like 14 (Fig. 1) we wished to apply RCM, which we and others have successfully reported on several occassions. 13 This led to the target bicyclic tripeptide 10. Retrosynthesis showed that bicycle 10 might be accessible through two consecutive macrocyclization steps starting from 12 ( Fig. 1 ). Since the preferred order of the macrocyclization steps, by RCM or RuAAC, 14 was not known (vide infra), precursor dipeptide 7 was proposed, in order to optimize the RCM in the presence of an azide moiety ( Fig. 1) . TMS-protected alkyne 3 was conveniently accessible from commercially available 4-hydroxy-D-phenylglycine (Scheme 1). After protection of the amine group, conversion of the phenolic hydroxy group to a methyl ether and preparation of the methyl ester, amino acid derivative 1 was subjected to iodination, according to Nicolaou and co-workers, 15 to give mono-iodo compound 2 in high yield (90%). After saponification of the methyl ester, the alkyne was installed by a Pd-catalyzed Sonogashira cross-coupling reaction to give protected phenylglycine building block 3 in an acceptable yield of 57%.
16
The synthesis of the required RCM-precursor 7 is shown in Scheme 2. To this end 2-allylaniline 4 was obtained by a Claisen rearrangement according to Brucelle and Renaud. 17 In a first attempt to couple aniline 4 to azido acid 5, 18 BOP/DIPEA as a coupling reagent did not afford anilide 6. Therefore, DCC in pyridine was used to form the anilide 6 in 54% yield since this combination of coupling reagent/solvent was effective in the coupling of the poor nucleophile 4-nitroaniline with amino acids. 19 After deprotection of anilide 6 by treatment with TFA, Boc-D-Alg-OH was coupled using BOP/DIPEA, and bisalkene dipeptide 7 was obtained in 92% yield over two steps.
As RCM precursor peptide 7 contained an azide moiety, the first 20 and second 21 generation Grubbs catalysts could not be used since the tricyclohexylphosphine ligands would likely reduce the azide into an amine via a Staudinger reduction. 22 Therefore, the second generation Hoveyda-Grubbs catalyst 23 was used in refluxing CH 2 Cl 2 and macrocyclic peptide 8 was isolated in 55% yield as a mixture of the E/Z diastereoisomers, as shown in Scheme 3 (8a (Z):8b (E) = 1:2.3). After Boc removal both diastereoisomers 8a, b could be separated by preparative HPLC and were characterized by NMR and LC-(HR)MS. In its protected form, both diastereoisomers (R t 32.97 and 33.36 min) of macrocycle 8 could not be separated (see, ESI Fig. SI-18 ). However, when an aliquot of 8 was treated with TFA to remove the Boc functionality, this resulted in a base line separation of both diastereoisomers 8a, b (R t 22.24 and 22.98 min, . The 1 H NMR spectrum of diastereoisomer 8a gave broad peaks at 25°C; fortunately at higher temperature, peak splitting was observed and at 80°C a well-defined J coupling of the olefinic protons could be derived (Fig. SI-11 ). This value, $8 Hz, corresponded to the Z-configuration of the double bond. The proton spectrum of diastereoisomer 8b had resulted already at 25°C in a well-defined J coupling of $13 Hz for the alkene bond indicating an E-geometry of 8b (Fig. SI-12 ). Thus, macrocycle 8 was treated with TFA and the resulting free a-amine coupled to alkyne derivative 3 in the presence of BOP/ DIPEA to afford the protected click precursor 9 in 54% overall yield (Scheme 3). Then, tripeptide 9 was treated with TBAF to remove the TMS functionality, and the unprotected alkyne which was isolated in 95% yield after column chromatography, subjected to RuAAC in THF/MeOH at 80°C under microwave irradiation in the presence of 10 mol% [Cp*RuCl] 4 . Bicyclic tripeptide 10 was isolated in 22% yield after column chromatography as a mixture of E/Z diastereoisomers. Heating at 80°C under microwave irradiation in the absence of [Cp*RuCl] 4 did not lead to any conversion. To improve the yield of cyclization, lower and higher catalyst loadings (5 and 15 mol%, respectively) were used which turned out to be ineffective since incomplete conversion of the starting material (at 5 mol%) or extensive formation of baseline compounds (at 15 mol%) were observed. As a control experiment, the unprotected alkyne was also subjected to regular CuAAC 25 in the presence of either CuI or [Cu(CH 3 CN) 4 ]PF 6 as the Cu + species; these reaction conditions did not lead to the formation of bicyclic tripeptide 10. This experiment showed that a 1,5-triazole moiety with a curved geometry was essential for ring closure since the more linear geometry of the 1,4-triazole was clearly incompatible with the topology of the bicyclic framework of tripeptide 10. Similar to macrocycle 8, the individual diastereoisomers of bicyclic tripeptide 11 (Z-11a and E-11b, respectively) could be obtained after Boc removal of 10 and purification by preparative HPLC. It is interesting to note that the Z:E ratio during the conversion of 8a, b into 11a, b shifted from 1:2.3 to 2:1, an indication that the Z-geometry of the alkene was favored in the bicyclic tripeptide topology. Since bicyclic tripeptide 11 can be used as a versatile building block in the synthesis of tricyclic heptapeptides to mimic the side-chain to side-chain connectivity pattern of vancomycin, hydrogenation of the double bond to an alkane bridge would be desirable to obtain a single isomer instead of an E/Z mixture of diastereoisomers. Therefore, several hydrogenation conditions in the presence of Pd/C, Raney Ni, and Pd(OH) 2 were investigated, unfortunately all were unsuccessful.
Two reverse reaction sequences to arrive at the desired bicyclic tripeptide 10 were also investigated, both starting from linear dipeptide 7 (Scheme 4). As the first step, Boc-protected 7 was trea- ted with TFA and the resulting amine coupled to alkyne derivative 3 in the presence of BOP/DIPEA to afford tripeptide 12 in 69% yield after purification by column chromatography. RCM of precursor peptide 12 in the presence of second generation Hoveyda-Grubbs catalyst in CH 2 Cl 2 or 1,2-dichloroethane did not result in the formation of alkene-bridged macrocycle 9. The progress of the reaction was monitored by LCMS, and although starting material had disappeared, the desired bicyclic peptide 9 could not be observed. In hindsight, it was assumed that the desired ene-ene RCM pathway was possibly overrun by the thermodynamically favored ene-yne reactivity to yield 2-silyl-substituted 1,3-dienes, which, however, were not identified. 26 Alternatively, TMS-protected precursor peptide 12 was treated with TBAF and subsequently subjected to RuAAC to install the triazole moiety as the cyclic constraint. Via this route, macrocycle 13 was obtained in an improved 41% yield compared to the above preparation of 10 (Scheme 3). Unfortunately, RCM of 13 did not result in the successful isolation of bicyclic tripeptide 10. TLC analysis indicated that conversion of the starting compound was incomplete and some baseline material was present, additionally the formation of bicyclic tripeptide 10 could not be observed by LCMS. The structures of bicyclic tripeptides 11a (as the Z-diastereoisomer) and 11b (as the E-diastereoisomer) were energy minimized using the simulated annealing protocol employing the AMBER99 force field using the YASARA Structure 10.5.2.1 software package. 27 The peptides were superimposed with the left half of the vancomycin-related balhimycin antibiotic comprising the ABC-ring system. 28 An RMSD of 0.76 and 0.58 Å over seven atoms was calculated (see Scheme 3 for atom numbering) of the superimpositions of 11a and 11b, respectively (Fig. 2) . To evaluate if this structural resemblance correlates with binding affinity toward Ac-Lys(Ac)-
and Ac-Lys(Ac)-D-Ala-D-Lac-OH, isothermal microcalorimetry (ITC) was performed, as shown in Table 1 . 29, 30 Based on these data, mimics 11a and 11b still bind Ac-Lys(Ac)-DAla-D-Ala-OH appreciably, considering that a large part of the 'clam' is missing, albeit at least 100-fold less compared to vancomycin. Bicycle 11b is somewhat more active than 11a, while binding toward Ac-Lys(Ac)-D-Ala-D-Lac-OH was comparable for all three receptor molecules. This was in line with the MIC-values obtained from a growth inhibition assay 31 of the Staphylococcus aureus ATCC 49320 strain, where values of 300 lg/mL (11b), >300 lg/mL (11a) and 2 lg/mL (VM) were found, respectively.
Although a reasonable structural resemblance was found, not unexpectedly, for efficient binding (and activity) some extra factors need to be addressed such as the proper alignment of hydrogen bonding and further rigidification, possibly in attempts to combine the ABC and CDE-ring systems.
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Conclusion
In conclusion, bicyclic tripeptide 10 as a mimic of the ABC-ring system was successfully synthesized starting from precursor dipeptide 7 following an RCM-coupling-RuAAC strategy. Mimics of this part of the vancomycin structure are less explored as only a single hydrogen bond contributes to the binding of Ac-Lys(Ac)- heptapeptides for possible effective mimicry of vancomycin in which ruthenium-based cyclization approaches will be used to control the topology and rigidity of the peptide backbone.
